Liposuction is a novel and minimally invasive procedure for treating persistent submental lymphedema in patients with previous head and neck cancer, according to an article published in the June ...

6107Background: Lymphedema is common in head and neck cancer survivors (HNCS). ... A multisite randomized trial of an advanced pneumatic compression device vs usual care for head and neck cancer ...

“Tactile is committed to elevating lymphedema therapy with meaningful evidence generation, and these early results validate Flexitouch Plus as an effective option in treating head and neck ...

“More than 90% of patients treated for head and neck cancer develop lymphedema 1 – resulting in swelling, fibrosis, difficulty swallowing, pain and other symptoms impacting quality of life ...

Background: More than 90% of head and neck cancer (HNC) survivors experience secondary head and neck lymphedema. Prompt identification and treatment are essential given the progressive nature of ...

“Another huge one is, don't get blood draws on an arm that has had lymph nodes removed.That, too, has no evidence behind it, so you'll now see that that's being removed from lymphedema precautions.” ...

The lymphedema treatment market is projected to reach US$ 11.58 billion by 2028 from US$ 8.15 ... Featuring Bio Compression, Tactile Medical and Smith & Nephew Among Others. Research and ... National ...

The risk factors for lymphedema include some cancer treatments, injury, immobility, cellulitis, venous conditions, and obesity. Learn more.

Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer SurvivorsMINNEAPOLIS, June 03, 2025 (GLOBE ...

"Tactile is committed to elevating lymphedema therapy with meaningful evidence generation, and these early results validate Flexitouch Plus as an effective option in treating head and neck ...